Correction: Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry

被引:0
|
作者
Wern Yew Ding
Ameenathul Mazaya Fawzy
Giulio Francesco Romiti
Marco Proietti
Daniele Pastori
Menno V. Huisman
Gregory Y. H. Lip
Ameenathul Mazaya Fawzy
机构
[1] University of Liverpool,Liverpool Centre for Cardiovascular Science
[2] Liverpool John Moores University and Liverpool Heart & Chest Hospital,Department of Translational and Precision Medicine
[3] Sapienza - University of Rome,Division of Subacute Care
[4] IRCCS Istituti Clinici Scientifici Maugeri,Department of Clinical Sciences and Community Health
[5] University of Milan,Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences
[6] Sapienza University of Rome,Department of Thrombosis and Hemostasis
[7] Leiden University Medical Center,Department of Clinical Medicine, Aalborg Thrombosis Research Unit
[8] Aalborg University,undefined
关键词
D O I
10.1007/s11239-023-02904-9
中图分类号
学科分类号
摘要
引用
收藏
页码:178 / 178
相关论文
共 50 条
  • [1] Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
    Ding, Wern Yew
    Fawzy, Ameenathul Mazaya
    Romiti, Giulio Francesco
    Proietti, Marco
    Pastori, Daniele
    Huisman, Menno V.
    Lip, Gregory Y. H.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (01) : 39 - 49
  • [2] Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
    Wern Yew Ding
    Ameenathul Mazaya Fawzy
    Giulio Francesco Romiti
    Marco Proietti
    Daniele Pastori
    Menno V. Huisman
    Gregory Y. H. Lip
    Journal of Thrombosis and Thrombolysis, 2024, 57 : 39 - 49
  • [3] Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: A report from the GLORIA-AF registry phase III
    Liu, Yang
    Chen, Yang
    Lam, Steven H. M.
    Huang, Bi
    Romiti, Giulio F.
    Alam, Uazman
    Chao, Tze Fan
    Olshansky, Brian
    Hong, Kui
    Huisman, Menno V.
    Lip, Gregory Y. H.
    DIABETES OBESITY & METABOLISM, 2024, 26 (12): : 5795 - 5804
  • [4] Incidence and risk factors for residual adverse events despite anticoagulation in atrial fibrillation: results from phase II/III of the GLORIA-AF registry
    Ding, W. Y.
    Lane, D. A.
    Gupta, D.
    Huisman, M. V.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2022, 43 : 516 - 516
  • [5] Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA-AF Registry
    Ding, Wern Yew
    Lane, Deirdre A.
    Gupta, Dhiraj
    Huisman, Menno V.
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (15):
  • [6] Renal function and adverse clinical events in anticoagulated patients with atrial fibrillation: insights from the GLORIA-AF Registry Phase III
    Liu, Yang
    Lam, Steven Ho Man
    Romiti, Giulio Francesco
    Huang, Bi
    Chen, Yang
    Chao, Tze Fan
    Olshansky, Brian
    Hong, Kui
    Huisman, Menno V.
    Lip, Gregory Y. H.
    GLORIA-AF Investigators
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2025, 58 (02) : 165 - 177
  • [7] Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation
    Miguel Rivera-Caravaca, Jose
    Marin, Francisco
    Asuncion Esteve-Pastor, Maria
    Rana-Miguez, Paula
    Anguita, Manuel
    Muniz, Javier
    Cequier, Angel
    Bertomeu-Martinez, Vicente
    Valdes, Mariano
    Vicente, Vicente
    Lip, Gregory Yoke Hong
    Roldan, Vanessa
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (12): : 2176 - 2181
  • [8] Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: implications of insulin treatment: a report from the GLORIA-AF Registry Phase III
    Liu, Y.
    Chen, Y.
    Lam, S. H. M.
    Huang, B.
    Chao, T. F.
    Olshansky, B.
    Huisman, M.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [9] Adverse outcomes according to metabolic status in obese and overweight patients with atrial fibrillation: a report from the GLORIA-AF Phase II and III Registry
    Corica, B.
    Romiti, G. F.
    Proietti, M.
    Mei, D. A.
    Boriani, G.
    Chao, T. F.
    Olshansky, B.
    Huisman, M. V.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [10] The 2MACE score predicts cardiovascular events in real-world patients with atrial fibrillation: The FANTASIIA registry
    Esteve Pastor, M. A.
    Perez-Copete, J.
    Rivera-Caravaca, J. M.
    Roldan, V.
    Roldan Rabadan, I.
    Muniz, J.
    Cequier, A.
    Bertomeu-Martinez, V.
    Badimon, L.
    Rana Miguez, P.
    Anguita, M.
    Lip, G. Y. H.
    Marin, F.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1126 - 1127